Impact Life Sciences 03/2025 Now Online
The newest Impact Life Sciences Special explores current technology trends in medical technology.
Industry experts provide insights into the field's geopolitics, regulatory challenges, and key factors behind successful medtech M&A transactions.
- Founders in diagnostics, digital health, and laboratory equipment have strong prospects for securing investment.
Dr Philipp Baaske, founder of NanoTemper Technologies and Vice President of Ludwig Maximilian University of Munich (LMU), shares his expertise in the cover interview.
A market overview examines the reasons behind the trend of investment in medtech.